Neonatal resuscitation

Published on 23/06/2015 by admin

Filed under Emergency Medicine

Last modified 23/06/2015

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1271 times

2.6 Neonatal resuscitation

Introduction

Epidemiology

Between 5 and 10% of newborns require some assistance to begin breathing at birth and, in developed countries, approximately 1% need intensive resuscitative measures to restore cardiorespiratory function. It has been estimated that birth asphyxia significantly contributes to approximately 20% of the five million neonatal deaths that occur worldwide each year; outcome might therefore be improved for more than one million newborns per year through effective resuscitation at birth.

Neonatal resuscitation is unique in that it is required at a time when the newborn is undergoing a predetermined process of transition from a liquid filled intrauterine environment to spontaneous breathing of room air. There is an accompanying sequence of dramatic alterations in physiology, each of which may be altered and require correction.

There are two important caveats in this process. First, the achievement of lung expansion with an appropriate oxygen-containing gas leading to establishment of a functional residual capacity and adequate spontaneous ventilation is of primary importance. Second, the significance of a vital sign abnormality depends greatly on the time since birth and the time during which effective resuscitation measures have been administered. For instance, bradycardia immediately after birth prior to any resuscitative manoeuvres likely indicates an intrapartum stress. The same heart rate after 1 to 2 minutes of adequate ventilation suggests a different range of aetiologies and requires a different resuscitative response.

The majority of circumstances where newborn resuscitation is needed can be predicted, allowing opportunity for preparation of appropriate equipment and personnel. Factors placing the newborn at high risk for neonatal resuscitation include those listed in Table 2.6.1, due to maternal, fetal and intrapartum circumstances.

Table 2.6.1 Risk factors for need for neonatal resuscitation

Maternal Fetal Intrapartum Premature or prolonged rupture of membranes Multiple gestation Fetal distress Antepartum haemorrhage Preterm (<35 weeks) or post-term Abnormal presentation Hypertension (>42 weeks) gestation Prolonged or precipitate labour Diabetes mellitus IUGR Thick staining of amniotic fluid Substance abuse Polyhydramnios Instrumental delivery or emergency caesarean section Maternal infection or chronic illness Congenital abnormalities   Absence of antenatal care    

IUGR, intrauterine growth retardation.

Preparation

Table 2.6.2 Equipment and drugs recommended for newborn resuscitation

Equipment Drugs Stethoscope Adrenaline (epinephrine) 1 in 1:10000 solution. Suction catheters (6–12 French) and suction Naloxone hydrochloride 1.0 or 0.4 mg mL–1 8 French feeding tube and 20 mL syringe for gastric decompression Dextrose 5% or 10% Face masks NaHCO3 4.2% solution Oropharyngeal (Guedel’s) airways Volume expander (0.9% saline or 4% HSA) Resuscitation system for PPV   Laryngoscope with straight blade   ET tubes 2.5 to 4 mm internal diameter   ET stylets   Tape for ETT and IV fixation   Cannulae, syringes and UV catheterisation equipment  

HSA, human serum albumin; PPV, positive pressure ventilation.

Ventilation

The initial assessment is an evaluation of the presence and quality of respirations.